---
title: BioPharma Services Inc. vs ResolveMass Laboratories Inc.
slug_a: biopharmaservices
slug_b: resolvemass
site: cro
review_signal_gate: closed
canonical_path: /compare/biopharmaservices/resolvemass
---

# BioPharma Services Inc. vs ResolveMass Laboratories Inc.

Side-by-side profile data from each company listing on this directory.

## BioPharma Services Inc.

- Profile: [/companies/biopharmaservices](/companies/biopharmaservices)

BioPharma Services Inc. — Full-service Phase 1 CRO specializing in early-stage clinical trials, bioequivalence/bioavailability studies, and human abuse potential assessments with state-of-the-art facilities in Toronto and in-house bioanalytical labs.

Services: 10. Modalities: 1. Indications: 4. Locations: 1. Certifications: 1. The strongest documented coverage currently appears in services (10).

### Services

- Bioanalysis
- LC-MS Bioanalysis (Small Molecule)
- Phase I Clinical Trials
- Phase II Clinical Trials
- Clinical Operations
- Data Management & eClinical
- Biostatistics & Statistical Programming
- Medical Writing
- Regulatory Affairs
- US FDA Regulatory Strategy

### Modalities

- Small Molecule

### Indications

- Immunology
- Neurology
- Cardiovascular
- Infectious Disease

### Phases

- Phase I
- Phase II

### Sourcing models

- Full-Service Outsourcing (FSO)

## ResolveMass Laboratories Inc.

- Profile: [/companies/resolvemass](/companies/resolvemass)

ResolveMass Laboratories Inc. — Canadian CRO and CDMO specializing in polymer synthesis, peptide characterization, and advanced analytical services for drug delivery and pharmaceutical development. FDA-registered and ISO 9001:2015 certified, serving North American pharmaceutical and biotech companies.

Services: 4. Modalities: 2. Indications: 0. Locations: 1. Certifications: 2. The strongest documented coverage currently appears in services (4).

### Services

- Medicinal Chemistry
- Regulatory Affairs
- US FDA Regulatory Strategy
- Analytical Method Development & Validation

### Modalities

- Small Molecule
- Peptide

### Indications

- Data not yet provided.

### Phases

- Preclinical (IND-Enabling)

### Sourcing models

- Full-Service Outsourcing (FSO)